{"id":4973,"date":"2023-08-03T15:44:34","date_gmt":"2023-08-03T15:44:34","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=4973"},"modified":"2023-08-03T15:51:10","modified_gmt":"2023-08-03T15:51:10","slug":"west-african-journal-of-pharmacy-2015-26-1-1-10","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2015-26-1-1-10\/","title":{"rendered":"West African Journal of Pharmacy (2015) 26 (1) 1-10"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4973\" class=\"elementor elementor-4973\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-623d0ced elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"623d0ced\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-70d87528\" data-id=\"70d87528\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2bff1126 elementor-widget elementor-widget-text-editor\" data-id=\"2bff1126\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: center;\"><b>Physician and patient preferences for sustained release antihypertensive preparations in the Kumasi\u00a0<\/b><b style=\"font-size: 19px; color: var( --e-global-color-text );\">metropolis, Ghana<\/b><\/p><p style=\"text-align: center;\">\u00a0<\/p><p style=\"text-align: center;\">Samuel L. Kipo , Christina Osei-Asare , Kwabena Ofori-Kwakye , Kwame O. Buabeng and Berko P. Anto<\/p><p style=\"text-align: center;\">1<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of<\/span><\/p><p style=\"text-align: center;\">\u00a0<\/p><p style=\"text-align: center;\">2\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Science and Technology, Kumasi, Ghana; Department of Clinical and Social Pharmacy, Faculty of Pharmacy and\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana<\/span><\/p><p style=\"text-align: center;\">\u00a0<\/p><p style=\"text-align: center;\">Corresponding author: Samuel L. Kipo<\/p><p style=\"text-align: center;\">Email: slkipo@yahoo.com Phone: +233 202520782<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6029bfc5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6029bfc5\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-17925c2c\" data-id=\"17925c2c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-61193218 elementor-widget elementor-widget-heading\" data-id=\"61193218\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-611fbb elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"611fbb\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4eee36d5\" data-id=\"4eee36d5\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-202b89cb elementor-widget elementor-widget-text-editor\" data-id=\"202b89cb\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: justify;\"><b>Background: <\/b>Non-adherence to therapy is a major reason for the low control rate of hypertension in Ghana\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">today. Sustained release (SR) antihypertensive preparations are useful in promoting adherence to therapy\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">because of the reduced daily dosing frequency, stable drug levels and reduced toxicity which enhances\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">compliance. One major concern about SR antihypertensives is whether they can be substituted with one\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">another to produce the same effect.<\/span><\/p><p style=\"text-align: justify;\"><b>Objectives:<\/b> This study sought to determine the preferences of physicians and patients for various SR\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">antihypertensive medications in the Kumasi metropolis of Ghana. The views of the respondents on whether\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">the brands of the most used SR antihypertensive were therapeutically equivalent and interchangeable were\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">ascertained.<\/span><\/p><p style=\"text-align: justify;\"><b>Methods:<\/b> Seventy-three (73) community pharmacies, 66 doctors and 150 patients in 50 public, private and\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">mission hospitals and clinics within the Kumasi metropolis were purposively sampled. Respondents were\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">interviewed via interviewer administered structured questionnaires and the information gathered was coded,\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">entered into SPSS software version (16) and analysed. The results were presented as frequencies and\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">proportions, and in tables as well as in figures.<\/span><\/p><p style=\"text-align: justify;\"><b>Results:<\/b> SR nifedipine was the most stocked and used SR antihypertensive drug while Nifecard XL (30 mg) was\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">the preferred brand of patients and doctors. Clinicians considered effectiveness and compliance as two major\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">reasons for their preference for SR nifedipine while patients considered affordability and availability. Sixty\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">percent of prescribers and 41% of patients were of the opinion that all brands of SR nifedipine were\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">interchangeable.<\/span><\/p><p style=\"text-align: justify;\"><b>Conclusion:<\/b> There is a gap between prescribers and patients about SR nifedipine brands interchangeability\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">which needs to be bridged to optimize their use to attain better treatment outcomes in Ghana. There is need\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">for continuous education on concepts of therapeutic equivalence and generics substitution for all\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">stakeholders to address the problem of non-adherence to hypertension therapy in Ghana.<\/span><\/p><p style=\"text-align: justify;\"><b>Keywords:<\/b> Sustained release, antihypertensive medications, nifedipine, generic drugs, drug\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">interchangeability<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2386ca7c elementor-align-right elementor-widget elementor-widget-button\" data-id=\"2386ca7c\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/wapcpharm.org\/journal\/wp-content\/uploads\/2023\/08\/Chapter-1-1_compressed.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Download <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Physician and patient preferences for sustained release antihypertensive preparations in the Kumasi\u00a0metropolis, Ghana \u00a0 Samuel L. Kipo , Christina Osei-Asare , Kwabena Ofori-Kwakye , Kwame O. Buabeng and Berko P. Anto 1Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of \u00a0 2\u00a0Science and Technology, Kumasi, Ghana; Department of Clinical and Social [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[234],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4973"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=4973"}],"version-history":[{"count":7,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4973\/revisions"}],"predecessor-version":[{"id":4982,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4973\/revisions\/4982"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=4973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=4973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=4973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}